Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$134.33

-0.6 (-0.44%)

06:33
08/29/18
08/29
06:33
08/29/18
06:33

Indian panel wants J&J to pay compensation over recalled implants, Reuters says

A government panel in India has recommended that Johnson & Johnson pay compensation of at least $28,500 to each Indian patient who suffered from artificial hip implants the company recalled eight years ago, Reuters reports, citing the panel. The company, which recalled the implants after data suggested they failed at a higher-than-expected rate, agreed to pay about $2.5B in 2013 to settle thousands of lawsuits from those in the U.S. who claimed they were injured by the implants and paid $2M to Indian patients for repeat surgeries as well as roughly $250,000 in related diagnostic costs under its ASR reimbursement program. Reference Link

  • 04

    Sep

  • 05

    Sep

  • 12

    Sep

  • 13

    Sep

  • 28

    Oct

JNJ Johnson & Johnson
$134.33

-0.6 (-0.44%)

08/27/18
OPCO
08/27/18
NO CHANGE
Target $60
OPCO
Outperform
Portola Pharmaceuticals price target lowered to $60 from $70 at Oppenheimer
Oppenheimer analyst Jay Olson lowered his price target for Portola Pharmaceuticals (PTLA) to $60 from $70 after results of the MARINER trial of Johnson & Johnson (JNJ) rivaroxaban in medically ill patients missed the primary endpoint. While the analyst sees MARINER results as positive for Portola's Bevyxxa due to less competition, highlighting the favorable product profile, he anticipates additional efforts remaining in order to gain access and drive demand. Olson reiterates an Outperform rating on Portola's shares.
08/27/18
08/27/18
UPGRADE
Target $34

Neutral
Portola Pharmaceuticals upgraded to Neutral as MARINER sinks at Credit Suisse
As previously reported, Credit Suisse analyst Vamil Divan upgraded Portola Pharmaceuticals (PTLA) to Neutral from Underperform after Johnson & Johnson (JNJ)/Bayer (BAYRY) presented disappointing data for Xarelto in the acute medically ill population at ESC. The analyst notes that the data avoids a worst case scenario for Portola's Bevyxxa by essentially removing a potentially strong competitor, but does put the pressure on Portola to successfully change medical practice on its own, without help from a larger player such as Johnson & Johnson. Divan also raised his price target on Portola's shares to $34 from $28.
08/27/18
WBLR
08/27/18
NO CHANGE
WBLR
Outperform
Mariner failure removes potential Portola competition, says William Blair
William Blair analyst Matt Phipps says that while the failure of Johnson & Johnson's (JNJ) Mariner trial removes potential competition Portola Pharmaceuticals' (PTLA) Bevyxxa, which is positive, "significant work" is still needed to gain adoption of Bevyxxa in the United States. As such, the Mariner results do not significantly alter the near-term headwinds for Bevyxxa, Phipps tells investors in a research note. The analyst believes getting beyond the Mariner presentation allows investors to focus on the opportunity for Andexxa, which he still thinks is "significant." He points out that Portola remains on track to file the prior approval supplement for the second-generation manufacturing process of Andexxa in the coming days, which would provide sufficient supply for 1,000 hospitals in the United States and expansion into Europe. Phipps keeps an Outperform rating on Portola Pharmaceuticals, which is up 5% to $29.60 in premarket trading.
08/27/18
MSCO
08/27/18
NO CHANGE
MSCO
Equal Weight
Portola may be up 'somewhat' on Xarelto trial failure, says Morgan Stanley
Morgan Stanley analyst Matthew Harrison noted the failure of Johnson & Johnson's (JNJ)MARINER study, which was examining Xarelto, a competing anticogulant to Portola's (PTLA) BevyxXa. MARINER's failure to demonstrate a statistically significant result of reducing symptomatic VTE or death due to VTE is expected by Harrison to send Portola shares up "somewhat," but he believes most investors had already lowered their expectations for the BevyxXa franchise after the Q2 report, making the impact modest. He maintains an Equal Weight rating on Portola shares, which are up 3% to $29 per share in early trading.

TODAY'S FREE FLY STORIES

PLCE

Children's Place

$109.92

2.95 (2.76%)

16:41
04/23/19
04/23
16:41
04/23/19
16:41
Initiation
Children's Place initiated  »

Children's Place…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TAC

TransAlta

$6.88

-0.175 (-2.48%)

16:40
04/23/19
04/23
16:40
04/23/19
16:40
Hot Stocks
Mangrove Partners commences action in Ontario court against TransAlta »

Mangrove Partners, one of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

CP

Canadian Pacific

$219.33

0.215 (0.10%)

16:39
04/23/19
04/23
16:39
04/23/19
16:39
Hot Stocks
Breaking Hot Stocks news story on Canadian Pacific »

Canadian Pacific drops 5%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 05

    Jun

  • 13

    Nov

LLY

Eli Lilly

$117.51

2.07 (1.79%)

16:39
04/23/19
04/23
16:39
04/23/19
16:39
Upgrade
Eli Lilly rating change  »

Eli Lilly upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 30

    Apr

  • 04

    May

  • 06

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 18

    May

16:38
04/23/19
04/23
16:38
04/23/19
16:38
General news
API crude inventories for week of April 19 »

API reports that crude…

MTH

Meritage Homes

$49.75

1.275 (2.63%)

16:38
04/23/19
04/23
16:38
04/23/19
16:38
Earnings
Meritage Homes sees FY19 EPS $4.65-$4.95, consensus $4.69 »

CEO Steven Hilton said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 17

    May

HZN

Horizon Global

$2.77

0.04 (1.47%)

16:36
04/23/19
04/23
16:36
04/23/19
16:36
Hot Stocks
Horizon Global board approves amendment to declassify board structure »

Horizon Global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BURL

Burlington Stores

$161.96

1.76 (1.10%)

16:36
04/23/19
04/23
16:36
04/23/19
16:36
Earnings
Burlington Stores narrows Q1 EPS view to $1.21-$1.25 from $1.21-$1.31 »

Q1 consensus $1.29.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

TRMK

Trustmark

$34.47

0.7 (2.07%)

16:36
04/23/19
04/23
16:36
04/23/19
16:36
Earnings
Trustmark reports Q1 EPS 51c, consensus 52c »

Reports Q1 net interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

PRK

Park National

$95.63

2.2 (2.35%)

16:36
04/23/19
04/23
16:36
04/23/19
16:36
Hot Stocks
Park National elects CEO Trautman as chairman and EVP Miller as president »

The board of directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

MTH

Meritage Homes

$49.75

1.275 (2.63%)

16:35
04/23/19
04/23
16:35
04/23/19
16:35
Earnings
Meritage Homes reports Q1 EPS 65c, consensus 64c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 17

    May

LRN

K12

$36.23

0.805 (2.27%)

16:35
04/23/19
04/23
16:35
04/23/19
16:35
Earnings
K12 sees FY19 revenue $1.005B-$1.01B, consensus $1.01B »

Sees FY19 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

LRN

K12

$36.23

0.805 (2.27%)

16:34
04/23/19
04/23
16:34
04/23/19
16:34
Earnings
K12 reports Q3 EPS 44c, consensus 37c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

ROST

Ross Stores

$97.85

0.06 (0.06%)

, BURL

Burlington Stores

$161.96

1.76 (1.10%)

16:34
04/23/19
04/23
16:34
04/23/19
16:34
Hot Stocks
Burlington Stores CEO Thomas Kingsbury to step down, Michael O'Sullivan succeeds »

Burlington Stores (BURL)…

ROST

Ross Stores

$97.85

0.06 (0.06%)

BURL

Burlington Stores

$161.96

1.76 (1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

NAVI

Navient

$12.45

0.38 (3.15%)

16:33
04/23/19
04/23
16:33
04/23/19
16:33
Earnings
Navient reports Q1 adjusted EPS 58c, consensus 44c »

Reports Q1 revenue $257M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 02

    May

KALU

Kaiser Aluminum

$107.59

2 (1.89%)

, BA

Boeing

$374.04

-0.98 (-0.26%)

16:33
04/23/19
04/23
16:33
04/23/19
16:33
Hot Stocks
Kaiser Aluminum says Boeing 737 build rate reduction introduces uncertainty »

"The recent…

KALU

Kaiser Aluminum

$107.59

2 (1.89%)

BA

Boeing

$374.04

-0.98 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 29

    Apr

  • 29

    May

  • 05

    Jun

DORM

Dorman Products

$93.44

0.53 (0.57%)

16:31
04/23/19
04/23
16:31
04/23/19
16:31
Hot Stocks
Dorman Products announces Joseph Braun as SVP and General Counsel »

Dorman Products announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

KALU

Kaiser Aluminum

$107.59

2 (1.89%)

16:31
04/23/19
04/23
16:31
04/23/19
16:31
Earnings
Kaiser Aluminum reports Q1 adjusted EPS $1.85, consensus $1.79 »

Reports Q1 revenue $395M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

TD

Toronto-Dominion

$56.14

-0.435 (-0.77%)

16:30
04/23/19
04/23
16:30
04/23/19
16:30
Hot Stocks
TD Bank Group sees TD Ameritrade's Q2 earnings to translate into C$266M »

TD Bank Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

NBHC

National Bank

$35.13

0.83 (2.42%)

16:30
04/23/19
04/23
16:30
04/23/19
16:30
Earnings
National Bank reports Q1 EPS 60c, consensus 51c »

Fully taxable equivalent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 09

    May

16:30
04/23/19
04/23
16:30
04/23/19
16:30
Options
Preliminary option volume of 19.3M today »

Preliminary option volume…

RHI

Robert Half

$68.83

1.46 (2.17%)

16:29
04/23/19
04/23
16:29
04/23/19
16:29
Earnings
Robert Half sees Q2 EPS 95c-$1.01, consensus $1.01 »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 22

    May

FE

FirstEnergy

$40.73

0.14 (0.34%)

16:28
04/23/19
04/23
16:28
04/23/19
16:28
Earnings
Breaking Earnings news story on FirstEnergy »

FirstEnergy backs FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 21

    May

FE

FirstEnergy

$40.73

0.14 (0.34%)

16:27
04/23/19
04/23
16:27
04/23/19
16:27
Earnings
Breaking Earnings news story on FirstEnergy »

FirstEnergy sees Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 21

    May

BXMT

Blackstone Mortgage

$35.04

0.38 (1.10%)

16:27
04/23/19
04/23
16:27
04/23/19
16:27
Earnings
Breaking Earnings news story on Blackstone Mortgage »

Blackstone Mortgage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 21

    May

  • 04

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.